Friday 17 June
Health Infrastructure will lead the design and delivery of its $49.6 million Stage 2 commercial-scale viral vector manufacturing facility located at the Westmead Health and Innovation District along with $51.8 million to accelerate viral vector products for both research and clinical trials.
NSW Premier Dominic Perrotett, NSW Treasurer, Minister for Energy and Environment Matt Kean, and Minister for Health & Medical Research Brad Hazzard announced the funding as part of a $270.3 million boost for biomedical research at its world-leading health and innovation precincts.
Manufacturing commercial grade viral vectors locally will secure viral vector supply for Australian researchers and give patients faster access to ground-breaking therapies to treat genetic diseases and cancer, and develop vaccines.
Investing in viral vector manufacturing and leveraging the state’s bio-medical technology and research expertise will keep NSW at the forefront of this industry.